Delivery Order SPE2DB22D2007-SPE2DB24FJ5VN

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $14,019.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division to supply XARELTO 20 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of critical pharmaceutical and medical supplies. As a major pharmaceutical distributor,...
This is a $11,181.32 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XARELTO 20 MG TABLET 90S, a prescription medication, with a period of performance through June 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $16,239.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XARELTO 20 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of March 5, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $15,466.62 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XARELTO 20 MG TABLET 30S, a cardiovascular medication, with a period of performance through August 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
The U.S. government's Defense Logistics Agency (DLA) awarded a $3,931.43 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XARELTO 20 MG TABLET 90S, a medication used to treat cardiovascular conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This is a $28,961.66 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. The contract does not have a set-aside designation and has a period of performance through August 26, 2024. AmerisourceBergen is a major pharmaceutical distributor...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $5,172.54, is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The ultimate completion date for this contract is August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $4,135.54 firm-fixed-price contract is for the supply of XARELTO 20 mg tablets, with a period of performance ending on October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of medical commodities, including...
This is a $41,887.60 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,827,884 units of the prescription medication Xarelto 20mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XARELTO 20 MG TABLET 90S. The $13,901.74 firm-fixed-price contract has an ultimate completion date of October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025. This IDC enables the DLA...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ5VN
    Delivery Order

This is a $14,139.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of XARELTO 20 mg tablets, a prescription medication, to support military treatment facilities and other federal healthcare providers. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded this contract as part of its broader role as a key supplier of pharmaceutical and medical products to various government agencies. The contract does not have a set-aside designation and is set to expire on September 6, 2024. AmerisourceBergen also holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000, respectively, for delivering a comprehensive range of medical commodities to support federal healthcare programs.

Generated 12/5/24, 10:23 AM